CG Oncology (CGON) Insider Trading & Ownership $26.96 +0.24 (+0.89%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CG Oncology (NASDAQ:CGON) Insider Buying and Selling ActivityNumber OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$42.66 M Get CGON Insider Trade Alerts Want to know when executives and insiders are buying or selling CG Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CGON Insider Buying and Selling by Quarter Remove Ads CG Oncology Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/13/2025Leonard E. PostDirectorSell1,000$29.66$29,660.00 12/16/2024Hong Fang SongDirectorSell700,000$28.00$19,600,000.00 12/6/2024Leonard E. PostDirectorSell1,000$34.54$34,540.00 8/29/2024Hong Fang SongDirectorSell650,455$35.36$23,000,088.80 (Data available from 1/1/2013 forward) CGON Insider Trading Activity - Frequently Asked Questions Who is on CG Oncology's Insider Roster? The list of insiders at CG Oncology includes Corleen M Roche, Decheng Capital Global Life Sc, Hong Fang Song, Leonard E. Post, and Vijay Kasturi. Learn more on insiders at CGON. Which CG Oncology insiders have been buying company stock? The following insiders have purchased CGON shares in the last 24 months: Corleen M Roche ($38,000.00), Decheng Capital Global Life Sc ($7,600,000.00), Hong Fang Song ($4,999,983.00), and Vijay Kasturi ($24,985.00). How much insider buying is happening at CG Oncology? Insiders have purchased a total of 666,472 CGON shares in the last 24 months for a total of $12,662,968.00 bought. Which CG Oncology insiders have been selling company stock? The following insiders have sold CGON shares in the last 24 months: Hong Fang Song ($42,600,088.80), and Leonard E. Post ($64,200.00). How much insider selling is happening at CG Oncology? Insiders have sold a total of 1,352,455 CG Oncology shares in the last 24 months for a total of $42,664,288.80 sold. CG Oncology Key ExecutivesMr. Arthur Kuan (Age 33)Chairman & CEO Compensation: $640.97kMr. Ambaw Bellete M.S. (Age 53)President & COO Compensation: $1.06MDr. Vijay Kasturi M.D. (Age 56)Chief Medical Officer Compensation: $212.24kMs. Corleen M. Roche (Age 57)CFO & Secretary Ms. Amy SteeleVice President of Finance, Accounting & AdministrationMr. Swapnil Bhargava Ph.D.Chief Technical OfficerMr. Bing KungVice President of Corporate Development More Insider Trading Tools from MarketBeat Related Companies Roivant Sciences Insider Buying Lantheus Insider Buying Revolution Medicines Insider Buying BridgeBio Pharma Insider Buying Axsome Therapeutics Insider Buying Grifols Insider Buying Blueprint Medicines Insider Buying Elanco Animal Health Insider Buying TG Therapeutics Insider Buying Verona Pharma Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in January This page (NASDAQ:CGON) was last updated on 3/10/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredYou are in denial—here’s whyDuring volatile market moves like the one we're in now, most people "freeze up." This is the "Denial" stage...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CG Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CG Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.